Schistosomiasis in 2012: current status and key research priorities required for control leading to elimination

Click to increase image sizeClick to decrease image size

Acknowledgements

The author thanks the chair (D Molyneux) and the other members of DRG 6 for valuable discussions and insight on the control of zoonotic and marginalized infections.

Financial & competing interests disclosure

The author has received funding from the National Health and Medical Research Council (Australia), Wellcome Trust (UK), The Sandler Foundation, the NIH, the WHO/TDR and the Australian Centre for Vaccine Technology for his work on schistosomiasis. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.